WCG
SPPI

Weaver Consulting Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Weaver Consulting Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-200
Closed -$2K – 973
2019
Q4 		$2K Hold
200
– – ﹤0.01% 769
2019
Q3 		$2K Hold
200
– – ﹤0.01% 750
2019
Q2 		$2K Hold
200
– – ﹤0.01% 741
2019
Q1 		$2K Buy
+200
New +$2.14K ﹤0.01% 1343

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weaver Consulting Group's SPPI Position: Q1 2020 in Review

Weaver Consulting Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 200 shares — an estimated $2K sold.

Weaver Consulting Group first reported a position in SPPI in Q1 2019 and held it in 4 quarters. The position peaked at $2K in Q4 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Weaver Consulting Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 200 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $2K.
  • Weaver Consulting Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 4 quarters.
  • Weaver Consulting Group's Spectrum Pharmaceuticals Inc position peaked at $2K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Weaver Consulting Group's 13F filing for Q1 2020, filed 28 Apr 2020.